Related Experiment Video
Updated: Sep 11, 2025

Author Spotlight: Implementation of BIVA for Analyzing Disease Risk Factors in Patients with Low Body Cell Mass
Published on: July 14, 2023
Circuit resistance training and Zataria Multiflora: a dual approach to improving blood rheology in postmenopausal
Seyed Morteza Tayebi1, Somayeh Ahmadabadi2, Aref Basereh3
1Department of Exercise Physiology, Faculty of Sports Science, Allameh Tabataba'i University, Tehran, Iran.
Background And Aims:
This study examined the effects of an 8-week Circuit Resistance Training (CRT) and Zataria Multiflora Supplementation (ZMS) on some Blood Rheological Factors in postmenopausal women.
Methods:
This was a pre-posttest design with control and experimental groups. Ninety-six postmenopausal women were divided randomly into eight groups: Control Group (CG, n = 12); Zataria Multiflora supplementation (ZMS, n = 12), Circuit Resistance Training with 35% 1RM (CRT35, n = 12), CRT 55% (n = 12), CRT 85% (n = 12), CRT 35% + ZMS (n = 12), CRT 55% + ZMS (n = 12) and CRT 85% + ZMS (n = 12). Blood samples were collected during pre-post-intervention sessions to measure Blood Rheological Factors, including Platelet Counts (PC), Mean Platelet Volume (MPV), Platelet Distribution Width (PDW), Plasma Viscosity (PV), Platelet-Large Cell Ratio (PLCR), High-density lipoprotein (HDL), Total Cholesterol (TC), and Triglyceride (TG).
Results:
The results showed no significant differences between different training intensities in PC, MPV, PDW, and PLCR (p > 0.05) but a significant difference was found between different training intensities in P.Vis, TC, TG, and P.Vol (p < 0.05). Also, ZMS significantly decreased TC, TG, and P.Vis (p < 0.05).
Conclusion:
Our findings suggest the 8-week CRT is a critical intervention element that can significantly modulate blood rheology. Interestingly, these effects intensified when Zataria Multiflora supplementation was added to the 8-week CRT program, whereas ZMS alone had little impact on blood rheology. This intervention, CRT, alone or in combination with ZMS, could be considered a non-pharmacologic treatment to modulate or minimize menopause-induced CVD risks and lead to improved well-being and quality of life among postmenopausal women.
More Related Videos
09:01Vascular Occlusion Training for Inclusion Body Myositis: A Novel Therapeutic Approach
Published on: June 5, 2010
10:21Evaluation of Hydration Status by Bioelectrical Impedance Vector Analysis in Patients with Ischemic Heart Disease Undergoing Exercise Stress Test
Published on: September 22, 2023
Related Concept Videos
Blood Pressure Imbalances and Circulatory Shock
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Menopause
Dysrhythmias VI: Management of Dysrhythmias
Hormonal Regulation of the Menstrual Cycle
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
Hormonal Regulation of Blood Pressure
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
Peripheral Artery Disease III: Interprofessional Care